Italia markets closed

BMY Jan 2025 115.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,02000,0000 (0,00%)
In data: 01:06PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,0200
Aperto0,0200
Denaro0,0100
Lettera0,0300
Prezzo d'esercizio115,00
Scadenza2025-01-17
Min-Max giorno0,0200 - 0,0200
Contratto - Min-MaxN/D
Volume30
Open Interest90
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri